Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 421

1.

Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.

Halfon P, Pénaranda G, Carrat F, Bedossa P, Bourlière M, Ouzan D, Renou C, Tran A, Rosenthal E, Wartelle C, Delasalle P, Cacoub P.

Aliment Pharmacol Ther. 2009 Jul;30(1):61-70. doi: 10.1111/j.1365-2036.2009.03995.x. Epub 2009 Mar 9.

PMID:
19292832
[PubMed - indexed for MEDLINE]
2.

Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients.

Merchante N, Rivero A, de Los Santos-Gil I, Merino D, Márquez M, López-Ruz MA, Rodríguez-Baño J, Del Valle J, Camacho A, Sanz-Sanz J, Macías J, Pérez-Camacho I, Gómez-Mateos J, Moro A, Pineda JA.

Gut. 2009 Dec;58(12):1654-60. doi: 10.1136/gut.2009.179085. Epub 2009 Jul 21.

PMID:
19625279
[PubMed - indexed for MEDLINE]
3.

Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.

Cholet F, Nousbaum JB, Richecoeur M, Oger E, Cauvin JM, Lagarde N, Robaszkiewicz M, Gouérou H.

Gastroenterol Clin Biol. 2004 Mar;28(3):272-8.

PMID:
15094677
[PubMed - indexed for MEDLINE]
Free Article
4.

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.

Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P.

Gastroenterology. 2008 Feb;134(2):416-23. doi: 10.1053/j.gastro.2007.11.010. Epub 2007 Nov 12.

PMID:
18164296
[PubMed - indexed for MEDLINE]
5.

Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.

Durante-Mangoni E, Zampino R, Marrone A, Tripodi MF, Rinaldi L, Restivo L, Cioffi M, Ruggiero G, Adinolfi LE.

Aliment Pharmacol Ther. 2006 Nov 1;24(9):1349-57.

PMID:
17059516
[PubMed - indexed for MEDLINE]
Free Article
6.

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan GW, George J.

Gastroenterology. 2003 Dec;125(6):1695-704. Erratum in: Gastroenterology. 2004 Feb;126(2):634.

PMID:
14724822
[PubMed - indexed for MEDLINE]
7.

Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.

Vidali M, Tripodi MF, Ivaldi A, Zampino R, Occhino G, Restivo L, Sutti S, Marrone A, Ruggiero G, Albano E, Adinolfi LE.

J Hepatol. 2008 Mar;48(3):399-406. doi: 10.1016/j.jhep.2007.10.011. Epub 2007 Dec 3.

PMID:
18164507
[PubMed - indexed for MEDLINE]
8.

Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.

Castéra L, Loko MA, Le Bail B, Coffie P, De Ledinghen V, Trimoulet P, Winnock M, Dabis F, Neau D; Groupe D'epidémiologie Clinique du Sida en Aquitaine (GECSA).

Aliment Pharmacol Ther. 2007 Dec;26(11-12):1489-98. Epub 2007 Sep 28.

PMID:
17903235
[PubMed - indexed for MEDLINE]
Free Article
9.

Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.

Kara B, Gunesacar R, Doran F, Kara IO, Akkiz H.

Adv Ther. 2007 Sep-Oct;24(5):972-82.

PMID:
18029322
[PubMed - indexed for MEDLINE]
10.

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.

Patel K, Thompson AJ, Chuang WL, Lee CM, Peng CY, Shanmuganathan G, Thongsawat S, Tanwandee T, Mahachai V, Pramoolsinsap C, Cho M, Han KH, Shah SR, Foster GR, Clark PJ, Pulkstenis E, Subramanian GM, McHutchison JG.

J Gastroenterol Hepatol. 2011 Jul;26(7):1182-8. doi: 10.1111/j.1440-1746.2011.06722.x.

PMID:
21410752
[PubMed - indexed for MEDLINE]
11.

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.

Clin Infect Dis. 2006 Apr 1;42(7):1032-9. Epub 2006 Feb 21.

PMID:
16511772
[PubMed - indexed for MEDLINE]
Free Article
12.

HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.

Borghi V, Puoti M, Mussini C, Bellelli S, Angeletti C, Sabbatini F, Prati F, Cossarizza A, Esposito R.

Antivir Ther. 2008;13(8):1057-65.

PMID:
19195331
[PubMed - indexed for MEDLINE]
13.

Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.

McGovern BH, Ditelberg JS, Taylor LE, Gandhi RT, Christopoulos KA, Chapman S, Schwartzapfel B, Rindler E, Fiorino AM, Zaman MT, Sax PE, Graeme-Cook F, Hibberd PL.

Clin Infect Dis. 2006 Aug 1;43(3):365-72. Epub 2006 Jun 22.

PMID:
16804853
[PubMed - indexed for MEDLINE]
Free Article
14.

Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.

Merchante N, Macías J, Ramayo E, Vergara S, García-García JA, Mira JA, Corzo JE, Gómez-Mateos JM, Lozano F, Pineda JA.

J Viral Hepat. 2006 Jul;13(7):449-56.

PMID:
16792538
[PubMed - indexed for MEDLINE]
15.

Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.

Bani-Sadr F, Carrat F, Bedossa P, Piroth L, Cacoub P, Perronne C, Degott C, Pol S; ANRS HC02 - Ribavic Study team.

AIDS. 2006 Feb 28;20(4):525-31.

PMID:
16470116
[PubMed - indexed for MEDLINE]
16.

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

Cammà C, Bruno S, Di Marco V, Di Bona D, Rumi M, Vinci M, Rebucci C, Cividini A, Pizzolanti G, Minola E, Mondelli MU, Colombo M, Pinzello G, Craxì A.

Hepatology. 2006 Jan;43(1):64-71.

PMID:
16374856
[PubMed - indexed for MEDLINE]
17.

Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.

Castera L.

Minerva Gastroenterol Dietol. 2006 Jun;52(2):125-34. Review.

PMID:
16557184
[PubMed - indexed for MEDLINE]
18.

[ANRS-fibrovic and homavic: role of non invasive markers of liver fibrosis and insulin resistance during antiviral treatment in HIV-HCV co-infected patients from ANRS HC 02 RIVABIC trial].

Halfon P, Pénaranda G, Cacoub P.

Gastroenterol Clin Biol. 2009 Mar;33 Suppl 2:S113-7. doi: 10.1016/S0399-8320(09)72451-0. French.

PMID:
19375039
[PubMed - indexed for MEDLINE]
Free Article
19.

Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection.

Gaslightwala I, Bini EJ.

J Hepatol. 2006 Jun;44(6):1026-32. Epub 2006 Mar 13.

PMID:
16618518
[PubMed - indexed for MEDLINE]
20.

Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort.

Neau D, Winnock M, Castéra L, Bail BL, Loko MA, Géraut L, Dupon M, Ragnaud JM, Lacoste D, Lafon ME, Bioulac-Sage P, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):168-73.

PMID:
17527092
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk